Triglav Skladi D.O.O. Acquires Shares of 4,980 Elevance Health, Inc. (NYSE:ELV)

Triglav Skladi D.O.O. purchased a new position in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 4,980 shares of the company's stock, valued at approximately $1,837,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Wealthcare Advisory Partners LLC increased its stake in Elevance Health by 40.9% in the 4th quarter. Wealthcare Advisory Partners LLC now owns 2,138 shares of the company's stock worth $789,000 after buying an additional 621 shares during the period. Merit Financial Group LLC increased its position in shares of Elevance Health by 6.0% during the fourth quarter. Merit Financial Group LLC now owns 3,418 shares of the company's stock worth $1,261,000 after acquiring an additional 192 shares during the period. Arkadios Wealth Advisors increased its position in shares of Elevance Health by 11.5% during the fourth quarter. Arkadios Wealth Advisors now owns 1,107 shares of the company's stock worth $408,000 after acquiring an additional 114 shares during the period. HF Advisory Group LLC raised its stake in shares of Elevance Health by 35.9% during the fourth quarter. HF Advisory Group LLC now owns 5,070 shares of the company's stock valued at $1,870,000 after acquiring an additional 1,339 shares in the last quarter. Finally, Liberty One Investment Management LLC boosted its holdings in shares of Elevance Health by 13.7% in the fourth quarter. Liberty One Investment Management LLC now owns 9,079 shares of the company's stock valued at $3,349,000 after purchasing an additional 1,096 shares during the period. 89.24% of the stock is owned by institutional investors.

Elevance Health Stock Performance

Shares of NYSE:ELV traded down $16.17 during midday trading on Thursday, reaching $383.95. The company's stock had a trading volume of 1,964,969 shares, compared to its average volume of 1,519,267. The firm has a market capitalization of $86.75 billion, a PE ratio of 14.99, a P/E/G ratio of 1.18 and a beta of 0.66. Elevance Health, Inc. has a twelve month low of $357.45 and a twelve month high of $567.26. The stock has a fifty day moving average of $421.75 and a 200 day moving average of $403.61. The company has a quick ratio of 1.50, a current ratio of 1.45 and a debt-to-equity ratio of 0.71.

Elevance Health (NYSE:ELV - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The company reported $11.97 earnings per share for the quarter, topping analysts' consensus estimates of $10.60 by $1.37. The firm had revenue of $48.77 billion for the quarter, compared to analyst estimates of $46.26 billion. Elevance Health had a net margin of 3.38% and a return on equity of 18.28%. On average, equities analysts expect that Elevance Health, Inc. will post 33.96 EPS for the current fiscal year.

Elevance Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Tuesday, June 10th will be given a dividend of $1.71 per share. The ex-dividend date of this dividend is Tuesday, June 10th. This represents a $6.84 annualized dividend and a yield of 1.78%. Elevance Health's dividend payout ratio is presently 26.69%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Mizuho lifted their target price on Elevance Health from $455.00 to $505.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Wall Street Zen upgraded Elevance Health from a "hold" rating to a "buy" rating in a research note on Thursday, March 20th. Barclays upped their price objective on shares of Elevance Health from $512.00 to $522.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 23rd. Royal Bank of Canada reissued an "outperform" rating and set a $478.00 target price on shares of Elevance Health in a research report on Wednesday, April 23rd. Finally, Argus set a $465.00 price objective on shares of Elevance Health in a research note on Friday, April 25th. Four investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $510.38.

Insider Activity at Elevance Health

In related news, EVP Charles Morgan Kendrick, Jr. sold 3,504 shares of the firm's stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $396.30, for a total transaction of $1,388,635.20. Following the sale, the executive vice president now owns 10,116 shares in the company, valued at approximately $4,008,970.80. This trade represents a 25.73% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Ronald W. Penczek sold 443 shares of the firm's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $415.13, for a total transaction of $183,902.59. Following the sale, the chief accounting officer now owns 1,847 shares in the company, valued at approximately $766,745.11. This represents a 19.34% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 8,535 shares of company stock worth $3,521,612. 0.29% of the stock is owned by company insiders.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.